世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040704

2型糖尿病の世界市場(2024-2028)

TechNavio

Global Type 2 Diabetes Market 2024-2028

発刊日 2024/07/12

言語英語

体裁PDF/184ページ

ライセンス/価格184ページ

0000040704

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

2型糖尿病市場は、2023年から2028年にかけて426 億米ドル成長すると予測されており、予測期間中のCAGRは10.84%で加速します。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。糖尿病有病率の上昇、肥満の有病率の上昇、ライフスタイルの変化、最近の製品承認などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ 薬剤クラス別
      ◇ インスリン
      ◇ DPP-4阻害薬
      ◇ GLP-1受容体作動薬
      ◇ SGLT-2阻害薬
      ◇ その他
    ➣ 流通チャネル別
      ◇ 小売薬局
      ◇ 病院薬局
      ◇ オンライン薬局
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査は、高齢者人口の増加が、今後数年間の2型糖尿病市場の成長を促進する主な理由の1つであることを特定しています。また、糖尿病に対する意識の高まり、治療法における取り組みや革新の拡大により、市場での大きな需要が見込まれるでしょう。

2型糖尿病市場に関するレポートは、次の分野をカバーしています。

  • 2型糖尿病市場の規模
  • 2型糖尿病市場の予測
  • 2型糖尿病市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Amgen Inc.
    ➣ AstraZeneca Plc
    ➣ Baxter International Inc.
    ➣ Biocon Ltd.
    ➣ Boehringer Ingelheim International GmbH
    ➣ Cadila Pharmaceuticals Ltd.
    ➣ Daiichi Sankyo Co. Ltd.
    ➣ DM Pharma Marketing Pvt. Ltd.
    ➣ Eli Lilly and Co.
    ➣ GlaxoSmithKline Plc
    ➣ Glenmark Pharmaceuticals Ltd.
    ➣ Johnson and Johnson Services Inc.
    ➣ Merck KGaA
    ➣ Novartis AG
    ➣ Novo Nordisk AS
    ➣ Pfizer Inc.
    ➣ Practo Technologies Pvt. Ltd.
    ➣ Sanofi SA
    ➣ 武田製薬工業(Takeda Pharmaceutical Co. Ltd.)
    ➣ Viatris Inc.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Drug Class
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ billion)
Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Type 2 Diabetes Market 2018 - 2022
Historic Market Size - Data Table on Global Type 2 Diabetes Market 2018 - 2022 ($ billion)
4.2 Drug Class segment analysis 2018 - 2022
Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Drug Class
6.1 Market segments
Chart on Drug Class - Market share 2023-2028 (%)
Data Table on Drug Class - Market share 2023-2028 (%)
6.2 Comparison by Drug Class
Chart on Comparison by Drug Class
Data Table on Comparison by Drug Class
6.3 Insulin - Market size and forecast 2023-2028
Chart on Insulin - Market size and forecast 2023-2028 ($ billion)
Data Table on Insulin - Market size and forecast 2023-2028 ($ billion)
Chart on Insulin - Year-over-year growth 2023-2028 (%)
Data Table on Insulin - Year-over-year growth 2023-2028 (%)
6.4 DPP-4 inhibitor - Market size and forecast 2023-2028
Chart on DPP-4 inhibitor - Market size and forecast 2023-2028 ($ billion)
Data Table on DPP-4 inhibitor - Market size and forecast 2023-2028 ($ billion)
Chart on DPP-4 inhibitor - Year-over-year growth 2023-2028 (%)
Data Table on DPP-4 inhibitor - Year-over-year growth 2023-2028 (%)
6.5 GLP-1 receptor agonists - Market size and forecast 2023-2028
Chart on GLP-1 receptor agonists - Market size and forecast 2023-2028 ($ billion)
Data Table on GLP-1 receptor agonists - Market size and forecast 2023-2028 ($ billion)
Chart on GLP-1 receptor agonists - Year-over-year growth 2023-2028 (%)
Data Table on GLP-1 receptor agonists - Year-over-year growth 2023-2028 (%)
6.6 SGLT-2 inhibitors - Market size and forecast 2023-2028
Chart on SGLT-2 inhibitors - Market size and forecast 2023-2028 ($ billion)
Data Table on SGLT-2 inhibitors - Market size and forecast 2023-2028 ($ billion)
Chart on SGLT-2 inhibitors - Year-over-year growth 2023-2028 (%)
Data Table on SGLT-2 inhibitors - Year-over-year growth 2023-2028 (%)
6.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ billion)
Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.8 Market opportunity by Drug Class
Market opportunity by Drug Class ($ billion)
Data Table on Market opportunity by Drug Class ($ billion)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Retail pharmacies - Market size and forecast 2023-2028
Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Hospital pharmacies - Market size and forecast 2023-2028
Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ billion)
Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ billion)
Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ billion)
Data Table on US - Market size and forecast 2023-2028 ($ billion)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ billion)
Data Table on China - Market size and forecast 2023-2028 ($ billion)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ billion)
Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ billion)
Data Table on India - Market size and forecast 2023-2028 ($ billion)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
12.5 Biocon Ltd.
Biocon Ltd. - Overview
Biocon Ltd. - Business segments
Biocon Ltd. - Key offerings
Biocon Ltd. - Segment focus
12.6 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
12.7 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
12.8 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.10 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key news
Glenmark Pharmaceuticals Ltd. - Key offerings
12.11 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.12 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.13 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.14 Novo Nordisk AS
Novo Nordisk AS - Overview
Novo Nordisk AS - Business segments
Novo Nordisk AS - Key news
Novo Nordisk AS - Key offerings
Novo Nordisk AS - Segment focus
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
12.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Type 2 Diabetes Market 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Drug Class Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Drug Class - Market share 2023-2028 (%)
Exhibits33: Data Table on Drug Class - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Drug Class
Exhibits35: Data Table on Comparison by Drug Class
Exhibits36: Chart on Insulin - Market size and forecast 2023-2028 ($ billion)
Exhibits37: Data Table on Insulin - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Chart on Insulin - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Insulin - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on DPP-4 inhibitor - Market size and forecast 2023-2028 ($ billion)
Exhibits41: Data Table on DPP-4 inhibitor - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Chart on DPP-4 inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on DPP-4 inhibitor - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on GLP-1 receptor agonists - Market size and forecast 2023-2028 ($ billion)
Exhibits45: Data Table on GLP-1 receptor agonists - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Chart on GLP-1 receptor agonists - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on GLP-1 receptor agonists - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on SGLT-2 inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on SGLT-2 inhibitors - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on SGLT-2 inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on SGLT-2 inhibitors - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Drug Class ($ billion)
Exhibits57: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits58: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits59: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits60: Chart on Comparison by Distribution Channel
Exhibits61: Data Table on Comparison by Distribution Channel
Exhibits62: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits63: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits67: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits70: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits71: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits73: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits74: Market opportunity by Distribution Channel ($ billion)
Exhibits75: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits78: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits82: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits86: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits90: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits98: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits110: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits111: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits113: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits114: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits115: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits116: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits117: Market opportunity By Geographical Landscape ($ billion)
Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits119: Impact of drivers and challenges in 2023 and 2028
Exhibits120: Overview on criticality of inputs and factors of differentiation
Exhibits121: Overview on factors of disruption
Exhibits122: Impact of key risks on business
Exhibits123: Companies covered
Exhibits124: Matrix on companies position and classification
Exhibits125: Amgen Inc. - Overview
Exhibits126: Amgen Inc. - Product / Service
Exhibits127: Amgen Inc. - Key news
Exhibits128: Amgen Inc. - Key offerings
Exhibits129: AstraZeneca Plc - Overview
Exhibits130: AstraZeneca Plc - Product / Service
Exhibits131: AstraZeneca Plc - Key news
Exhibits132: AstraZeneca Plc - Key offerings
Exhibits133: Biocon Ltd. - Overview
Exhibits134: Biocon Ltd. - Business segments
Exhibits135: Biocon Ltd. - Key offerings
Exhibits136: Biocon Ltd. - Segment focus
Exhibits137: Boehringer Ingelheim International GmbH - Overview
Exhibits138: Boehringer Ingelheim International GmbH - Product / Service
Exhibits139: Boehringer Ingelheim International GmbH - Key news
Exhibits140: Boehringer Ingelheim International GmbH - Key offerings
Exhibits141: Cadila Pharmaceuticals Ltd. - Overview
Exhibits142: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits143: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits144: Daiichi Sankyo Co. Ltd. - Overview
Exhibits145: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits146: Daiichi Sankyo Co. Ltd. - Key news
Exhibits147: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits148: Eli Lilly and Co. - Overview
Exhibits149: Eli Lilly and Co. - Product / Service
Exhibits150: Eli Lilly and Co. - Key news
Exhibits151: Eli Lilly and Co. - Key offerings
Exhibits152: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits153: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits154: Glenmark Pharmaceuticals Ltd. - Key news
Exhibits155: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits156: Johnson and Johnson Services Inc. - Overview
Exhibits157: Johnson and Johnson Services Inc. - Business segments
Exhibits158: Johnson and Johnson Services Inc. - Key news
Exhibits159: Johnson and Johnson Services Inc. - Key offerings
Exhibits160: Johnson and Johnson Services Inc. - Segment focus
Exhibits161: Merck KGaA - Overview
Exhibits162: Merck KGaA - Business segments
Exhibits163: Merck KGaA - Key news
Exhibits164: Merck KGaA - Key offerings
Exhibits165: Merck KGaA - Segment focus
Exhibits166: Novartis AG - Overview
Exhibits167: Novartis AG - Business segments
Exhibits168: Novartis AG - Key news
Exhibits169: Novartis AG - Key offerings
Exhibits170: Novartis AG - Segment focus
Exhibits171: Novo Nordisk AS - Overview
Exhibits172: Novo Nordisk AS - Business segments
Exhibits173: Novo Nordisk AS - Key news
Exhibits174: Novo Nordisk AS - Key offerings
Exhibits175: Novo Nordisk AS - Segment focus
Exhibits176: Pfizer Inc. - Overview
Exhibits177: Pfizer Inc. - Product / Service
Exhibits178: Pfizer Inc. - Key news
Exhibits179: Pfizer Inc. - Key offerings
Exhibits180: Sanofi SA - Overview
Exhibits181: Sanofi SA - Business segments
Exhibits182: Sanofi SA - Key news
Exhibits183: Sanofi SA - Key offerings
Exhibits184: Sanofi SA - Segment focus
Exhibits185: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits186: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits187: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits188: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits189: Inclusions checklist
Exhibits190: Exclusions checklist
Exhibits191: Currency conversion rates for US$
Exhibits192: Research methodology
Exhibits193: Information sources
Exhibits194: Data validation
Exhibits195: Validation techniques employed for market sizing
Exhibits196: Data synthesis
Exhibits197: 360 degree market analysis
Exhibits198: List of abbreviations

この商品のレポートナンバー

0000040704

TOP